Epigenetic changes play important roles in cancer, metabolic and aging-related diseases, but also during loss of resilience as they cause the genetic material to be incorrectly interpreted in affected cells. A major study by scientists at Helmholtz Munich published in Nature now provides important new insights into how complex epigenetic modification signatures regulate the genome. This study will pave the way for new treatments of diseases caused by faulty epigenetic machineries.
The Unresolved Mystery of Epigenetic Complexity
Our bodies are made up of hundreds of different cell types, each with its unique shape and function. The information on how to build an organism is stored in our DNA. However, while all our cells share the same DNA, they don’t all read it in the same way. So how does, for example, a liver or a brain cell know which instructions to follow? To make this possible, small chemical tags, so-called epigenetic modifications, are used. They act like flags and tell each cell which parts of the DNA to use and which ones to ignore.
Simple at first glance, this epigenetic regulation is much more complex, as there are many different modifications that can either be attached directly to our DNA or to so-called histone proteins. “Histones are small proteins around which our DNA is wrapped, and which thereby serve to package the genetic material,” says study leader Dr. Till Bartke, deputy director of the Institute of Functional Epigenetics (IFE) at Helmholtz Munich. “Depending on how the histones or the DNA are chemically modified, they can have different effects on the DNA and thereby control gene activity.” Together, epigenetic modifications form what scientists call the epigenetic code, allowing cells to switch genes on or off according to their specific needs.
However, how these epigenetic modifications work together has remained a big puzzle. Finding out how this epigenetic code works is the focus of the research at the Institute of Functional Epigenetics led by Prof. Robert Schneider: “Our understanding of the complex interaction between our DNA and epigenetic mechanisms has now taken an important step forward with this groundbreaking study from our institute.”
Cracking the Epigenetic Code in a Test Tube
To decipher the epigenetic code, Till Bartke and co-workers developed a creative way to examine how different combinations of epigenetic modifications work together. They reconstructed many of these modifications in a test tube and carried out experiments to study how they interact with the proteins in our cells, using a combination of sophisticated biochemical and mass spectrometric methods.
“Epigenetic modifications usually act in cooperation with so-called epigenetic reader proteins that recognize them and promote downstream effects” explains Dr. Andrey Tvardovskiy, post-doctoral researcher and one of the first authors of the study. “Uncovering how epigenetic readers interpret such complex modification signatures is therefore key to understanding how our genome functions and how its misregulation can lead to human diseases.” For the first time, the researchers could see how different combinations of modifications are “read” and translated by the protein machineries in our cells.
Decoding the Epigenetic Language with a Computer
Using newly developed AI approaches, they next set out to decode the language of epigenetic modifications. The researchers found that some constituents of the epigenetic code have a big impact, especially on stretches of the DNA that control gene activation, while others have a smaller effect. By putting together all this information, they managed to extract several fundamental rules of how our genetic material is organized and controlled inside our cells. These insights are highly relevant for many scientists across different fields and are anticipated to catalyze many future discoveries. To ensure that their findings are as widely available as possible, the researchers built a website called the ‘Modification Atlas of Regulation by Chromatin States’ (https://marcs.helmholtz-munich.de), that provides an intuitive interactive online resource to explore the results of their study.
Understanding Epigenetics to Treat Human Diseases
“Since epigenetic modifications play crucial roles in everything our bodies do, from growing and learning to staying healthy, things go wrong when the modifications are misplaced or misread. Often this causes diseases like cancer, developmental disorders, or mental disabilities” says Till Bartke. “But epigenetic changes also accumulate throughout life and are affected by the environment, nutrition, and lifestyle — this can contribute to diseases such as diabetes and lead to deleterious effects of aging.” By understanding how epigenetic modifications work and what goes wrong in diseases, researchers at the IFE aim to develop new ways to treat these diseases and tackle adaptation to a changing environment.
About the scientists
Dr. Till Bartke, Deputy Director of the Institute of Functional Epigenetics at Helmholtz Munich
Dr. Andrey Tvardovskiy, Postdoc at the Institute of Functional Epigenetics at Helmholtz Munich
Prof. Dr. Robert Schneider, Director of the Institute of Functional Epigenetics at Helmholtz Munich
